US Stock MarketDetailed Quotes

SRTS Sensus Healthcare

Watchlist
  • 5.510
  • +0.010+0.18%
Close Feb 14 16:00 ET
  • 5.533
  • +0.023+0.42%
Post 20:01 ET
90.89MMarket Cap13.44P/E (TTM)

Sensus Healthcare Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
71.31%41.81M
3.98%13.07M
126.76%8.84M
104.09%9.24M
212.33%10.66M
-45.20%24.41M
-4.10%12.57M
-56.74%3.9M
-62.52%4.53M
-66.98%3.41M
Operating revenue
71.31%41.81M
3.98%13.07M
126.76%8.84M
104.09%9.24M
212.33%10.66M
-45.20%24.41M
-4.10%12.57M
-56.74%3.9M
-62.52%4.53M
-66.98%3.41M
Cost of revenue
67.97%17.38M
25.84%5.96M
88.53%3.6M
100.00%3.82M
123.27%4M
-30.59%10.35M
-0.38%4.74M
-39.13%1.91M
-50.10%1.91M
-43.81%1.79M
Gross profit
73.76%24.43M
-9.25%7.11M
163.45%5.24M
107.06%5.42M
310.73%6.66M
-52.54%14.06M
-6.22%7.83M
-66.14%1.99M
-68.28%2.62M
-77.31%1.62M
Operating expense
13.15%16.34M
138.73%5.38M
-3.58%3.75M
-8.14%3.44M
-17.23%3.78M
-2.40%14.44M
-46.05%2.25M
4.61%3.88M
1.63%3.75M
41.69%4.56M
Selling and administrative expenses
12.64%12.13M
142.23%3.82M
2.89%2.88M
-11.94%2.58M
-17.73%2.85M
-5.05%10.76M
-47.78%1.58M
-5.59%2.8M
2.27%2.92M
39.02%3.46M
-Selling and marketing expense
-11.23%4.98M
124.64%1.4M
1.47%1.31M
-37.55%996K
-39.49%1.27M
-11.39%5.61M
-60.34%625K
-28.61%1.29M
-7.70%1.6M
72.33%2.1M
-General and administrative expense
38.62%7.15M
153.78%2.42M
4.10%1.57M
18.81%1.58M
15.76%1.58M
2.96%5.16M
-34.07%952K
30.26%1.51M
17.51%1.33M
7.15%1.36M
Research and development costs
14.63%4.22M
130.58%1.56M
-20.31%863K
5.35%866K
-15.66%926K
6.30%3.68M
-41.54%677K
45.17%1.08M
-0.60%822K
50.82%1.1M
Operating profit
2,217.80%8.09M
-69.05%1.73M
178.89%1.5M
275.87%1.98M
198.23%2.89M
-102.58%-382K
33.68%5.58M
-187.69%-1.9M
-124.66%-1.13M
-174.78%-2.94M
Net non-operating interest income expense
-6.05%932K
0.88%230K
0.72%279K
-14.69%209K
-11.93%214K
161.05%992K
-2.98%228K
134.75%277K
920.83%245K
24,200.00%243K
Non-operating interest income
----
----
0.72%279K
-14.69%209K
-11.93%214K
161.05%992K
-2.15%228K
132.77%277K
880.00%245K
24,200.00%243K
Total other finance cost
---932K
---230K
----
----
----
----
----
----
----
----
Other net income (expense)
-99.67%42K
0
42K
Special income (charges)
--0
--0
--0
----
----
-99.67%42K
--0
--42K
----
----
-Gain on sale of property,plant,equipment
--0
--0
--0
----
----
-99.67%42K
--0
--42K
----
----
Income before tax
1,283.74%9.02M
-66.30%1.96M
212.56%1.77M
348.41%2.19M
215.02%3.1M
-97.67%652K
31.72%5.81M
-169.15%-1.58M
-119.20%-882K
-116.13%-2.7M
Income tax
1,322.16%2.38M
-74.29%410K
547.20%559K
215.34%579K
203.12%827K
-95.54%167K
1.08%1.6M
-127.78%-125K
-146.92%-502K
-223.77%-802K
Net income
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
Net income continuous Operations
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
Minority interest income
Net income attributable to the parent company
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
-98.00%485K
48.82%4.21M
-179.33%-1.45M
-110.78%-380K
-111.79%-1.89M
Basic earnings per share
1,266.67%0.41
-65.38%0.09
177.78%0.07
600.00%0.1
216.67%0.14
-97.96%0.03
52.94%0.26
-181.82%-0.09
-109.52%-0.02
-112.37%-0.12
Diluted earnings per share
1,266.67%0.41
-65.38%0.09
177.78%0.07
600.00%0.1
216.67%0.14
-97.95%0.03
52.94%0.26
-181.82%-0.09
-109.52%-0.02
-112.37%-0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 71.31%41.81M3.98%13.07M126.76%8.84M104.09%9.24M212.33%10.66M-45.20%24.41M-4.10%12.57M-56.74%3.9M-62.52%4.53M-66.98%3.41M
Operating revenue 71.31%41.81M3.98%13.07M126.76%8.84M104.09%9.24M212.33%10.66M-45.20%24.41M-4.10%12.57M-56.74%3.9M-62.52%4.53M-66.98%3.41M
Cost of revenue 67.97%17.38M25.84%5.96M88.53%3.6M100.00%3.82M123.27%4M-30.59%10.35M-0.38%4.74M-39.13%1.91M-50.10%1.91M-43.81%1.79M
Gross profit 73.76%24.43M-9.25%7.11M163.45%5.24M107.06%5.42M310.73%6.66M-52.54%14.06M-6.22%7.83M-66.14%1.99M-68.28%2.62M-77.31%1.62M
Operating expense 13.15%16.34M138.73%5.38M-3.58%3.75M-8.14%3.44M-17.23%3.78M-2.40%14.44M-46.05%2.25M4.61%3.88M1.63%3.75M41.69%4.56M
Selling and administrative expenses 12.64%12.13M142.23%3.82M2.89%2.88M-11.94%2.58M-17.73%2.85M-5.05%10.76M-47.78%1.58M-5.59%2.8M2.27%2.92M39.02%3.46M
-Selling and marketing expense -11.23%4.98M124.64%1.4M1.47%1.31M-37.55%996K-39.49%1.27M-11.39%5.61M-60.34%625K-28.61%1.29M-7.70%1.6M72.33%2.1M
-General and administrative expense 38.62%7.15M153.78%2.42M4.10%1.57M18.81%1.58M15.76%1.58M2.96%5.16M-34.07%952K30.26%1.51M17.51%1.33M7.15%1.36M
Research and development costs 14.63%4.22M130.58%1.56M-20.31%863K5.35%866K-15.66%926K6.30%3.68M-41.54%677K45.17%1.08M-0.60%822K50.82%1.1M
Operating profit 2,217.80%8.09M-69.05%1.73M178.89%1.5M275.87%1.98M198.23%2.89M-102.58%-382K33.68%5.58M-187.69%-1.9M-124.66%-1.13M-174.78%-2.94M
Net non-operating interest income expense -6.05%932K0.88%230K0.72%279K-14.69%209K-11.93%214K161.05%992K-2.98%228K134.75%277K920.83%245K24,200.00%243K
Non-operating interest income --------0.72%279K-14.69%209K-11.93%214K161.05%992K-2.15%228K132.77%277K880.00%245K24,200.00%243K
Total other finance cost ---932K---230K--------------------------------
Other net income (expense) -99.67%42K042K
Special income (charges) --0--0--0---------99.67%42K--0--42K--------
-Gain on sale of property,plant,equipment --0--0--0---------99.67%42K--0--42K--------
Income before tax 1,283.74%9.02M-66.30%1.96M212.56%1.77M348.41%2.19M215.02%3.1M-97.67%652K31.72%5.81M-169.15%-1.58M-119.20%-882K-116.13%-2.7M
Income tax 1,322.16%2.38M-74.29%410K547.20%559K215.34%579K203.12%827K-95.54%167K1.08%1.6M-127.78%-125K-146.92%-502K-223.77%-802K
Net income 1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M
Net income continuous Operations 1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M
Minority interest income
Net income attributable to the parent company 1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M-98.00%485K48.82%4.21M-179.33%-1.45M-110.78%-380K-111.79%-1.89M
Basic earnings per share 1,266.67%0.41-65.38%0.09177.78%0.07600.00%0.1216.67%0.14-97.96%0.0352.94%0.26-181.82%-0.09-109.52%-0.02-112.37%-0.12
Diluted earnings per share 1,266.67%0.41-65.38%0.09177.78%0.07600.00%0.1216.67%0.14-97.95%0.0352.94%0.26-181.82%-0.09-109.52%-0.02-112.37%-0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More